Common use of Updates to Commercialization Plan Clause in Contracts

Updates to Commercialization Plan. On an annual basis no later than September 30th of each year (except as set forth in Section 6.2.1), Pfizer shall create and submit to the JSC for its review and discussion of the Commercialization Plan for the following calendar year. Each Commercialization Plan shall contain a five (5) year rolling annual plan for the Commercialization of the Product in the Territory for use in the Field. The first year of such plan (except the initial Commercialization Plan as set forth in Section 6.2.1), shall constitute the plan and budget for the first year and the remaining four (4) years shall be for planning purposes only (provided that Pfizer shall prepare such four (4) year portion in accordance with its good faith anticipated activities). Upon review and discussion by the JSC, Pfizer shall finalize the Commercialization Plan for the following calendar year. From time to time during a given calendar year, Pfizer may propose written updates to the Commercialization Plan for review and discussion by the JSC. Pfizer shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.

Updates to Commercialization Plan. On an annual basis no later than September 30th October 31st of each year (except as set forth in Section 6.2.1), Pfizer Sobi shall create prepare and submit to the JSC for its review and discussion of the Commercialization Plan for the following calendar year. Each The Commercialization Plan shall contain a five (5) year rolling annual plan for the Commercialization of the Finished Product in the Territory for use in the Field. The first year of such plan (except the initial Commercialization Plan as set forth in Section 6.2.1), shall constitute the plan and budget for the first year and the remaining four (4) years shall be for planning purposes only (provided that Pfizer Sobi shall prepare such four (4) year portion in accordance with its good faith anticipated activities). Upon review and discussion by the JSC, Pfizer Sobi shall finalize the Commercialization Plan for the following calendar year. From time to time during a given calendar year, Pfizer Sobi may propose written updates to the Commercialization Plan for review and discussion by the JSC. Pfizer Sobi shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.

Updates to Commercialization Plan. On an annual basis no later than September 30th October 31st of each year (except as set forth in Section 6.2.1), Pfizer Actelion shall create prepare and submit to the JSC for its review and discussion of the Commercialization Plan for the following calendar year. Each The Commercialization Plan shall contain a five (5) year rolling annual plan for the Commercialization of the Finished Product in the Territory for use in the Field. The first year of such plan (except the initial Commercialization Plan as set forth in Section 6.2.1), shall constitute the plan and budget for the first year and the remaining four (4) years shall be for planning purposes only (provided that Pfizer Actelion shall prepare such four (4) year portion in accordance with its good faith anticipated activities). Upon review and discussion by the JSC, Pfizer Actelion shall finalize the Commercialization Plan for the following calendar year. From time to time during a given calendar year, Pfizer Actelion may propose written updates to the Commercialization Plan for review and discussion by the JSC. Pfizer Actelion shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.